About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Washington | 32 Studies

Clinical Trials DiabetesWashington

Diabetes Clinical Trials in Washington

Find 32 clinical trials for diabetes near Washington. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-32 of 32 trials

CompletedAn Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesThis is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace.NCT00229658·Birmingham, Alabama and 106 others

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of UseThe purpose of this study is to demonstrate the performance of the Enlite Sensor over an entire calibration and wear period of 146 hours (6 days) when inserted in the abdomen and…NCT01464346·Chula Vista, California and 6 others

CompletedAn Inpatient Performance Evaluation of a New Subcutaneous Glucose SensorThe purpose of the study is to assess the performance of a new subcutaneous glucose sensor over a seven-day sensor life when used with currently marketed Medtronic Diabetes…NCT01112696·Escondido, California and 2 others

WithdrawnA Performance Evaluation of the Enlite 3 SensorThe purpose of this study is to support the use of the Enlite 3 sensor in arm and thigh in subjects age 14 - 75 years and provide additional characterization of the Enlite 3…NCT02649010·Walnut Creek, California and 1 other

CompletedEvaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring SystemThe purpose of this study is to demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring (GM) System interstitial glucose results against Reader capillary Blood…NCT02073058·Escondido, California and 3 others

Active not recruitingGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesThe purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync…NCT07228117·Little Rock, Arkansas and 32 others

WithdrawnSYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 DiabetesThe purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes.NCT06719531·Birmingham, Alabama and 27 others

CompletedClinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusThis open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing…NCT00108004·Anaheim, California and 47 others

CompletedAffects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisThe purpose of this study is to test the safety and effectiveness of two dosage levels (10mg and 20mg) of TZP-102 compared to placebo (capsule that looks like the study drug but…NCT01452815·Huntsville, Alabama and 51 others

CompletedAdult Accuracy Study of the Enlite 3 Glucose SensorThe purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and…NCT02246582·Escondido, California and 5 others

CompletedImpact of Acetaminophen on Performance of Guardian™ Sensor (3) in AdultsThe purpose of this study is to characterize the impact of acetaminophen ingestion on the performance of the Guardian™ Sensor (3) (i.e., C algorithm and Zeus algorithm) in…NCT04378114·Escondido, California and 5 others

CompletedSingle Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient PatientsThe purpose of this study is to evaluate the safety and tolerability of single and multiple doses of intramuscular INGAP Peptide given for the first time in humans as a potential…NCT00034255·San Diego, California and 3 others

PreviousPage 2 of 2

Other Conditions in Washington

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia